Evidence map›Paper›PMID 40338850›Full record

ArticleAIDS (London, England)2025

Broadly neutralizing antibodies, nonneutralizing antibodies and broadly effector antibodies to prevent HIV transmission?

Philippe Van de Perre, Penny L Moore, Nicolas Nagot, Lucio Gama, Jean-Pierre Moles

Abstract read
In one paragraph

Article in AIDS (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Philippe Van de PerrePathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS; CHU Montpellier, Montpellier, France.
Penny L MooreSA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand.
Nicolas NagotPathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS; CHU Montpellier, Montpellier, France.
Lucio GamaVaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA.
Jean-Pierre MolesPathogenesis and Control of Chronic and Emerging Infections, Montpellier University, INSERM, EFS; CHU Montpellier, Montpellier, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antibody-dependent cellular cytotoxicityantibody-dependent cellular phagocytosisantibody-dependent complement-mediated lysisbreastfeedingbroadly neutralizing antibodiesFc-mediated effector functionsHIVnonneutralizing antibodiespassive immunoprophylaxis

Identifiers

PMID40338850
PMCPMC12077333

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.